CeriBell, Inc. logo

CBLL Earnings Date: Nov 3, 2026 (Estimated) — CeriBell, Inc.

NASDAQ · Healthcare · Medical Devices

Updated

Price $27.26
Market Cap $1.0B
P/E -15.4
52W Range $10.85 – $28.19
Next Earnings · After close (est.)

When is CBLL's next earnings date?

CeriBell, Inc. (CBLL) is expected to report Q3 2026 earnings on Tuesday, November 3, 2026 at 4:00 PM ET (after market close); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of -$0.50 on revenue of $29.2M.

How did CBLL do in its last earnings report?

In its most recent report on Aug 10, 2026 (Q2 2026), CeriBell, Inc. posted EPS of -$0.51 versus the -$0.47 estimate, a miss of 10.9%. Revenue was $28.1M against a $27.3M estimate. The stock's 1-day post-earnings move was +10.4%.

How much does CBLL stock move after earnings?

CBLL beat EPS estimates in 3 of its last 6 reported quarters. Over the last 6 reports the stock moved an average of 9.4% (up or down) in the day after earnings.

About CeriBell, Inc.

CeriBell, Inc. specializes in pioneering artificial intelligence (AI)-powered electroencephalography (EEG) solutions designed for the immediate diagnosis and treatment of neurological conditions directly at the patient's bedside. The company's primary offering is the Ceribell System, an innovative, on-site EEG platform engineered to fulfill crucial, previously unmet requirements for patients in urgent medical environments. Beyond the core system, CeriBell also provides single-use EEG headbands and compact, battery-powered recording devices. Originally established in 2014 as Brain Stethoscope, Inc., the company underwent a name change to CeriBell, Inc. in August 2015. Its headquarters are located in Sunnyvale, California.

Earnings History

DatePeriodEPS Est.EPS Act.SurpriseRevenueResult1D Δ1W Δ1M Δ
2026-08-10Q2 2026-0.47-0.51-10.87%$28.1M❌ Miss+10.41%+26.42%+26.48%
2026-05-11Q1 2026-0.39-0.52-33.33%$26.5M❌ Miss-16.50%-17.35%-8.37%
2026-02-24Q4 2025-0.42-0.36+14.29%$24.8M✅ Beat-4.77%-11.86%-5.68%
2025-11-04Q3 2025-0.42-0.37+11.90%$22.6M✅ Beat+7.88%+14.65%+75.37%
2025-08-05Q2 2025-0.40-0.38+5.00%$21.2M✅ Beat-15.25%-22.41%-18.24%
2025-02-25Q4 2024-0.31-0.40-29.03%$18.5M❌ Miss-1.33%-6.97%-23.38%

Showing last 6 quarters.

Revenue by segment & region

By segment

Q2 FY26 · $28.1M total

SegmentShareRevenueYoY
Product75.6%$21.2M+33.4%
Subscription24.4%$6.9M+29.9%

Source: company filings via FMP. YoY compares the same fiscal period a year earlier.

Related Companies

Learn More

Explore More

Financial data from licensed market-data providers; risk factors from SEC EDGAR filings. AI-powered analysis. Data last updated .